The multidisciplinary Watchman™ Left Atrial Appendage Closure (LAAC) team at the CHI Health Heart Institute has extensive experience in procedural treatment of cardiovascular arrhythmias. The LAAC team is part of the Structural Heart Clinic and has been trained to implant the FDA-approved Watchman™ device. In addition, the CHI Health Heart Institute is a select site for clinical research, offering the latest in device technology through access to clinical trials.
The Watchman™ Left Atrial Appendage (LAA) Closure Technology is a minimally invasive, advanced therapy used to treat some patients living with Atrial Fibrillation (AF) who are at increased risk for stroke. Patients who are implanted with a Watchman device are followed through the Arrhythmia Clinic at the CHI Health Heart Institute.
Watchman is an umbrella-like device that is placed using a catheter. It is the only FDA-approved LAA closure device that effectively reduces stroke risk from thromboembolism from the left atrial appendage in patients with atrial fibrillation.
The Watchman is one of several treatments available through the Structural Heart Clinic at the CHI Health Heart Institute. The clinic provides therapy options for patients with persistent or permanent AF who are difficult to treat or continue to experience symptoms.
A multidisciplinary team of electrophysiologists, cardiologists, surgeons, and nurse coordinators work with patients to determine the most appropriate and effective therapy to enhance quality of life. Nurse Coordinators assist patients throughout the course of care with work-up assessments, procedure planning, monitoring, and long-term follow up.
If your doctor is suggesting a consultation for Left Atrial Appendage Closure, request a referral to the CHI Health Heart Institute Structural Heart Clinic. You or your physician may contact us by calling (402) 717-7153 (Omaha) or (402) 327-2700 (Lincoln).
